Literature DB >> 1872569

In vitro evaluation of a heparinized blood sampler for ionized calcium measurement.

C Sachs1, P Rabouine, M Chaneac, C Kindermans, M Dechaux.   

Abstract

When ionized calcium measurements are needed urgently blood has to be sampled with an anticoagulant to allow rapid specimen processing. Heparinate salts cause a decrease in ionized calcium by binding which is clinically significant when the concentration exceeds 15 IU/mL of whole blood. The use of an anticoagulant in an aqueous state induces 'solution-dilution' errors. To avoid these two types of error the use of calcium-titrated sodium heparinate in a dry state has been proposed. However, in this situation the actual calcium concentration could be modified if its value were different from the titration level. This possibility has been studied using a commercially available sampler (Radiometer B-129). When the sampler was used as recommended, errors were non-significant around 1.25 mmol/L. There was a +3% increase for low (0.75 mmol/L) values and a -2% decrease for high (2.50 mmol/L) values. Incomplete syringe filling increased these errors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872569     DOI: 10.1177/000456329102800307

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

1.  Liquid heparin anticoagulant produces more negative bias in the determination of ionized magnesium than ionized calcium.

Authors:  Cheung Soo Shin; Chul Ho Chang; Jeong-Ho Kim
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

2.  Usefulness and feasibility of measuring ionized calcium in haemodialysis patients.

Authors:  Guillaume Jean; Samuel Granjon; Eric Zaoui; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Charles Chazot
Journal:  Clin Kidney J       Date:  2015-06-03

3.  Whole blood versus serum ionized calcium concentrations in dialysis patients.

Authors:  Seok Hui Kang; Kyu Hyang Cho; Jong Won Park; Kyung Woo Yoon; Jun Young Do
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.